nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

07.08.2018 | Letter to the Editor

⁹⁰Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach

verfasst von: Luca Filippi, Orazio Schillaci, Oreste Bagni

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Ho CL, Chen S, Cheung SK, et al. Radioembolization with ⁹⁰Y glass microspheres for hepatocellular carcinoma: significance of pretreatment ¹¹C-acetate and ¹⁸F-FDG PET/CT and posttreatment ⁹⁰Y PET/CT in individualized dose prescription. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-4064-6.CrossRefPubMed

Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011;140(2):497–507.CrossRefPubMed

Ahmadzadehfar H, Essler M. It is time to move forward into the era of Theranostics. EJNMMI Res. 2018;8(1):9 https://doi.org/10.1186/s13550-018-0364-x.CrossRefPubMedPubMedCentral

Haug AR. Imaging of primary liver tumors with positron-emission tomography. Q J Nucl Med Mol Imaging. 2017;61(3):292–300 https://doi.org/10.23736/S1824-4785.17.02994-6.CrossRefPubMed

Ma W, Jia J, Wang S, Bai W, Yi J, Bai M, et al. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE). Theranostics. 2014;4(7):736–44.CrossRefPubMedCentralPubMed

Filippi L, Di Costanzo GG, D'Agostini A, Tortora R, Pelle G, Cianni R, et al. Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis. Nucl Med Commun. 2018. https://doi.org/10.1097/MNM.0000000000000879.CrossRefPubMed

Titel: 90Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach
verfasst von: Luca Filippi
Orazio Schillaci
Oreste Bagni
Publikationsdatum: 07.08.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-4115-z

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

⁹⁰Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach

Excerpt

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis

Correction to: Regulation of human brown adipose tissue by adenosine and A2A receptors – studies with [15O]H2O and [11C]TMSX PET/CT

Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?

Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription

Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging